Antibiotic market to reach US$ 74.07 billion by 2033; FDA approves GSK’s Blujepa for uncomplicated UTIs

Data Compilation
#PharmaFlow

Pipeline Prospector November 2025: Kimberly-Clark to buy Kenvue for US$ 48.7 bn; FDA approves Novartis’ gene therapy

Stock Recap
#PipelineProspector

beta-D-Fructopyranose, 2,3:4,5-bis-O-(1-methylethylidene)-, sulfamate

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

91 API Suppliers, 26 USDMF, 4 CEP/COS, 5 JDMF, 14 EU WC, 38 KDMF, 32 NDC API, 28 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

44 Drugs in Development

44 Drugs in Development

INTERMEDIATES

3 Intermediate Suppliers

3 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

2714 FDF Dossiers, 202 FDA Orange Book, 2287 Europe, 52 Canada, 54 Australia, 45 South Africa, 74 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET;ORAL - 100MG, TABLET;ORAL - 200MG, TABLET;ORAL - 25MG, TABLET;ORAL - 50MG, CAPSULE, EXTENDED RELEASE;ORAL - 100MG, CAPSULE, EXTENDED RELEASE;ORAL - 150MG, CAPSULE, EXTENDED RELEASE;ORAL - 200MG, CAPSULE, EXTENDED RELEASE;ORAL - 25MG, CAPSULE, EXTENDED RELEASE;ORAL - 50MG

RELATED EXCIPIENT COMPANIES

2 EUROAPI, 3 Rochem International Inc, 17 SPI Pharma, 13 DKSH, 1 Pharm-RX Chemical, 4 Boai NKY Pharmaceuticals Ltd, 6 Gangwal Healthcare, 11 Nanjing Well Pharmaceutical, 2 Pfanstiehl, 4 Kirsch Pharma, 4 ACG Worldwide, 9 Actylis, 1 Aeon Procare, 8 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 1 Ashland, 28 BASF, 2 CD Formulation, 2 Clariant, 11 Corel Pharma Chem, 7 DFE Pharma, 1 Esteem Industries, 2 Finar, 12 Gangwal Chemicals, 5 Ideal Cures, 5 Ingredion Pharma Solutions, 26 Kerry, 3 Keval Exports, 4 Kima Chemical, 6 Lonza Capsugel, 15 Microlex e.U, 1 Nanjing Bold Chemical, 2 Nitika Pharmaceutical Specialities, 2 Nomisma Healthcare, 3 Novo Excipients, 3 Pharmatrans-Sanaq, 8 Pluviaendo, 4 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 2 Qualicaps, 20 Roquette, 16 Seppic, 7 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shanghai Welltone Material Technology Co., Ltd, 1 Shijiazhuang Huaxu Pharmaceutical, 11 Sigachi Industries, 4 Silverline Chemicals, 3 The Dow Chemical Company, 1 Ulanqab Kema New Material, 1 Valens Pharmachem, 4 Vasa Pharmachem, 1 Vertellus

EXCIPIENTS BY APPLICATIONS

76 Fillers, Diluents & Binders, 53 Coating Systems & Additives, 38 Direct Compression, 35 Thickeners and Stabilizers, 34 Granulation, 32 Disintegrants & Superdisintegrants, 30 Solubilizers, 30 Controlled & Modified Release, 29 Topical, 26 Parenteral, 24 Taste Masking, 22 Film Formers & Plasticizers, 19 Lubricants & Glidants, 18 Chewable & Orodispersible Aids, 15 Co-Processed Excipients, 13 Emulsifying Agents, 10 Rheology Modifiers, 9 Empty Capsules, 8 Surfactant & Foaming Agents, 8 API Stability Enhancers, 5 Coloring Agents, 4 Vegetarian Capsules

DIGITAL CONTENT

1 Data Compilation #PharmaFlow, 70 News #PharmaBuzz

GLOBAL SALES INFORMATION

25 US Medicaid Prescriptions, 131 Regulatory FDF Prices, 1 Annual Reports

MARKET PLACE

20 APIs, 3 FDF Dossiers

PATENTS & EXCLUSIVITIES

140 US Patents, 10 US Exclusivities, 3 Health Canada Patents

REF. STANDARDS & IMPURITIES

5 Others

5 Others

$ Xls download

Filters

Last Updated on PharmaCompass	Virtual Booth	Country	Certificate Holder	Certificate No.	Substance	Issue Date	Status	Type	End Date	Substance No.
29/11/2025	Aurobindo Pharma Limited	India	APITORIA PHARMA PRIVATE LIMITED Hyderabad IN	CEP 2020-140 - Rev 04	Topiramate	2025-03-21	Valid	Chemical		2616
29/11/2025	Hetero Drugs	India	HETERO DRUGS LIMITED Hyderabad IN	R0-CEP 2020-130 - Rev 01	Topiramate	2023-03-06	Valid	Chemical		2616

Beta-D-Fructopyranose, 2,3:4,5-bis-O-(1-methylethylidene)-, Sulfamate

beta-D-Fructopyranose, 2,3:4,5-bis-O-(1-methylethylidene)-, sulfamate

ACCESS ALL DATA

Browse all information

CHEMISTRY

Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

91 API Suppliers

26 USDMF

4 CEP/COS

5 JDMF

14 EU WC

38 KDMF

32 NDC API

28 Listed Suppliers

$ API Reference Price

DEVELOPMENTS

44 Drugs in Development

INTERMEDIATES

3 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

2714 FDF Dossiers

202 FDA Orange Book

2287 Europe

52 Canada

54 Australia

45 South Africa

74 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET;ORAL - 100MG

TABLET;ORAL - 200MG

TABLET;ORAL - 25MG

TABLET;ORAL - 50MG

CAPSULE, EXTENDED RELEASE;ORAL - 100MG

CAPSULE, EXTENDED RELEASE;ORAL - 150MG

CAPSULE, EXTENDED RELEASE;ORAL - 200MG

CAPSULE, EXTENDED RELEASE;ORAL - 25MG

CAPSULE, EXTENDED RELEASE;ORAL - 50MG

RELATED EXCIPIENT COMPANIES

2 EUROAPI

3 Rochem International Inc

17 SPI Pharma

13 DKSH

1 Pharm-RX Chemical

4 Boai NKY Pharmaceuticals Ltd

6 Gangwal Healthcare

11 Nanjing Well Pharmaceutical

2 Pfanstiehl

4 Kirsch Pharma

4 ACG Worldwide

9 Actylis

1 Aeon Procare

8 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd

1 Ashland

28 BASF

2 CD Formulation

2 Clariant

11 Corel Pharma Chem

7 DFE Pharma

1 Esteem Industries

2 Finar

12 Gangwal Chemicals

5 Ideal Cures

5 Ingredion Pharma Solutions

26 Kerry

3 Keval Exports

4 Kima Chemical

6 Lonza Capsugel

15 Microlex e.U

1 Nanjing Bold Chemical

2 Nitika Pharmaceutical Specialities

2 Nomisma Healthcare

3 Novo Excipients

3 Pharmatrans-Sanaq

8 Pluviaendo

4 Prachin Chemical

1 Qianhao Chemical (Hebei) Co., Ltd

2 Qualicaps

20 Roquette

16 Seppic